Found: 121
Select item for more details and to access through your institution.
The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 8, p. 1921, doi. 10.1111/bcp.16082
- By:
- Publication type:
- Article
Frequency and Severity of Hypoglycemia Under Conditions of Increased Hypoglycemic Risk with Insulin Efsitora Alfa Versus Insulin Glargine Treatment in Participants with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1785, doi. 10.1007/s13300-024-01605-7
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1941, doi. 10.1111/dom.15510
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with EU‐ und US‐sourced reference insulins.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3817, doi. 10.1111/dom.15281
- By:
- Publication type:
- Article
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2023, v. 46, n. 5, p. 998, doi. 10.2337/dc22-1710
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1, doi. 10.1111/dom.15067
- By:
- Publication type:
- Article
A co‐formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1241, doi. 10.1111/dom.14972
- By:
- Publication type:
- Article
Oral insulin: A history of ambition, failure and data torturing.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 940, doi. 10.1111/dom.14984
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1080, doi. 10.1111/dom.14956
- By:
- Publication type:
- Article
Safety, tolerability, pharmacodynamics and pharmacokinetics following once‐daily doses of BI 187004, an inhibitor of 11 beta‐hydroxysteroid dehydrogenase‐1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 832, doi. 10.1111/dom.14932
- By:
- Publication type:
- Article
Limited evidence for sympathetic neural overactivation in older patients with type 2 diabetes mellitus.
- Published in:
- Frontiers in Neuroscience, 2023, v. 16, p. 1, doi. 10.3389/fnins.2022.1107752
- By:
- Publication type:
- Article
Association of HbA1c with VO 2max in Individuals with Type 1 Diabetes: A Systematic Review and Meta-Analysis.
- Published in:
- Membranes, 2022, v. 12, n. 11, p. 1017, doi. 10.3390/metabo12111017
- By:
- Publication type:
- Article
Association of HbA1c with VO 2max in Individuals with Type 1 Diabetes: A Systematic Review and Meta-Analysis.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 11, p. 1017, doi. 10.3390/metabo12111017
- By:
- Publication type:
- Article
What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1689, doi. 10.1111/dom.14773
- By:
- Publication type:
- Article
A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage.
- Published in:
- Frontiers in Aging, 2022, p. 1, doi. 10.3389/fragi.2022.852569
- By:
- Publication type:
- Article
Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 3, p. 413, doi. 10.1007/s40262-021-01084-0
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of BI 187004, an inhibitor of 11beta-hydroxysteroid dehydrogenase-1, in healthy male volunteers with overweight or obesity.
- Published in:
- Clinical Diabetes & Endocrinology, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40842-021-00130-x
- By:
- Publication type:
- Article
740-P: Proposed Biosimilar Gan & Lee Insulin Glargine (GL-GLA) Shows Pharmacokinetic (PK) and Pharmacodynamic (PD) Bioequivalence (BE) to U.S.- and EU-Licensed Insulin Glargine (IG).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-740-P
- By:
- Publication type:
- Article
197-OR: ADO09, a Coformulation of Insulin A21G and Pramlintide (Pram), Improves Blood Glucose Control and Reduces Body Weight in Subjects with T1D.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-197-OR
- By:
- Publication type:
- Article
738-P: Proposed Biosimilar Gan & Lee Insulin Aspart (GL-ASP) Shows Pharmacokinetic (PK) and Pharmacodynamic (PD) Bioequivalence (BE) to U.S.- and EU-Licensed Insulin Aspart (ASP).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-738-P
- By:
- Publication type:
- Article
736-P: Proposed Biosimilar Gan & Lee Insulin Lispro (GL-LIS) Shows Pharmacokinetic (PK) and Pharmacodynamic (PD) Bioequivalence (BE) vs. U.S.- and EU-Licensed Insulin Lispro (LIS).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-736-P
- By:
- Publication type:
- Article
Improving the Assessment of Flow-Mediated Dilation Through Detection of Peak Time in Healthy Subjects and Subjects With Type 2 Diabetes.
- Published in:
- Angiology, 2021, v. 72, n. 5, p. 434, doi. 10.1177/0003319720984884
- By:
- Publication type:
- Article
Cover Image, Volume 23, Issue 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 1, doi. 10.1111/dom.14378
- By:
- Publication type:
- Article
ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 961, doi. 10.1111/dom.14302
- By:
- Publication type:
- Article
Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter].
- Published in:
- 2021
- By:
- Publication type:
- Letter
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5).
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 619, doi. 10.1111/dom.14257
- By:
- Publication type:
- Article
Sustained Intensive Treatment and Long-term Effects on HbA<sub>1c</sub> Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Differences in Physiological Responses to Cardiopulmonary Exercise Testing in Adults With and Without Type 1 Diabetes: A Pooled Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog<sup>®</sup> (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1601, doi. 10.1007/s40262-020-00901-2
- By:
- Publication type:
- Article
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
- Published in:
- Pediatric Diabetes, 2020, v. 21, n. 8, p. 1375, doi. 10.1111/pedi.13105
- By:
- Publication type:
- Article
Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pains and needs of patients with type 2 diabetes as targets for novel technologies.
- Published in:
- Clinical Diabetology, 2020, v. 9, n. 6, p. 400, doi. 10.5603/DK.2020.0052
- By:
- Publication type:
- Article
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1789, doi. 10.1111/dom.14094
- By:
- Publication type:
- Article
The Association Between HbA<sub>1c</sub> and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4).
- Published in:
- 2020
- By:
- Publication type:
- journal article
237-OR: Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-237-OR
- By:
- Publication type:
- Article
64-OR: Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-64-OR
- By:
- Publication type:
- Article
112-LB: ADO09, a Coformulation of Pramlintide (PRAM) and Insulin A21G, Improves Postprandial Glucose vs. Novolog in Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-112-LB
- By:
- Publication type:
- Article
25-OR: Acid–Base Changes during Diabetic Ketoacidosis (DKA) in T1DM with and without SGLT2 Inhibitor (SGLT2i).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-25-OR
- By:
- Publication type:
- Article
951-P: Cotadutide (MEDI0382), a Dual Receptor Agonist with Glucagon-Like Peptide-1 and Glucagon Activity, Is Well Tolerated (<600 µG) with Robust Effects on Blood Glucose in Patients with T2DM.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-951-P
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL‐1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 521, doi. 10.1111/dom.13919
- By:
- Publication type:
- Article
Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Better glycaemic control with BioChaperone glargine lispro co‐formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1570, doi. 10.1111/dom.13685
- By:
- Publication type:
- Article
1112-P: Ultra Rapid Lispro (URLi) Lowers Postprandial Glucose (PPG) and More Closely Matches Normal Physiological Glucose Response Compared with Other Rapid Insulin Analogs.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1112-P
- By:
- Publication type:
- Article
2216-PUB: More Precise Assessment of Flow-Mediated Dilation (FMD) by Measuring at Maximum Dilatory Peak Time (MDP) in Subjects With and Without Type 2 Diabetes (T2D).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2216-PUB
- By:
- Publication type:
- Article
1100-P: Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Patients with T2D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1100-P
- By:
- Publication type:
- Article
150-OR: BioChaperone Pramlintide Insulin (BCPramIns), a New Co-Formulation of Pramlintide (PRAM) and Human Insulin (INS), Improves Postprandial Blood Glucose (BG) vs. Both Separate Injections of PRAM+INS and Insulin Lispro (LIS) in Subjects with T1D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-150-OR
- By:
- Publication type:
- Article
1017-P: Continuous Glucose Monitoring Reveals Comprehensive Glucose Control with MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1017-P
- By:
- Publication type:
- Article